Sentences with phrase «clinical leaders in»
As a clinical leader in the pediatric obesity initiative, she is taking the «bull by the horns», and using the new science of obesity, redesigning the weight loss and health promotion protocol to benefit all children.»
https://empoweredwellness.com/ Not exact matches
As an exec at Shire (shpg), which with $ 6 billion in revenue is one of the smaller Big Pharmas, he spent months persuading leaders and commercial and supply - chain people to launch a clinical trial for the ADHD drug Vyvanse to treat binge eating.
A global leader in science innovation, Thermo Fisher Scientific has offer remote jobs in the science research industry for health system specialists, clinical supply chain managers, field service engineers, recruiters, and global product managers.
She is a worship leader, freedom fighter, blogger, and recently completed her second masters in Clinical Mental Health Counseling.
Quality starts here: Arla Foods Ingredients is a global leader in natural whey ingredients for products in a range of categories — from sports nutrition, beverages, bakery, dairy and ice cream to clinical and infant nutrition.
Despite this, the 25 - year - old has the tendency to miss clear - cut chances, and he may have to be more clinical in front of goal versus the Premier League leaders.
In addition to maintaining an active clinical practice, Dr. Adams is a national lecturer, workshop leader, and consultant in the areas of child abuse, dysfunctional family systems, and sex addictioIn addition to maintaining an active clinical practice, Dr. Adams is a national lecturer, workshop leader, and consultant in the areas of child abuse, dysfunctional family systems, and sex addictioin the areas of child abuse, dysfunctional family systems, and sex addiction.
Adele Grant, LCSW, is an API Leader in New York City and a Licensed Clinical Social Worker.
Her blend of clinical psychology and eastern mindfulness sets her apart as a leader in the field of mindfulness psychology.
He is an expert in the use of systems - based methods to improve patient outcomes, a leading researcher in use of large scale clinical laboratories and electronic health records to improve the effectiveness and efficiency of care, and a nationally recognized thought leader in the very methods needed to transition to the future of lower - cost, more patient - centered, health care for the 21st century.
This program offers a unique opportunity for outstanding, mid-career U.S. professionalsÑacademics, government officials, clinical leaders, decision makers in managed care and other private health care organizations, and journalistsÑto spend up to 10 months in Australia conducting research and working with Australian health policy experts on issues relevant to both countries.
It is a world leader in bioscience and medical research, especially in terms of toxicology testing and clinical trials.
She is a key national leader in the field of mentoring and mentor training in clinical and translational sciences, including the unique aspects of team mentoring.
Sponsors and CROs feel that there is no clear technology leader in the clinical trials arena.
A leader in the field of mentoring and mentor training in clinical and translational sciences, Joan M. Lakoski offers «Top 10 Tips to Maximize Your Mentoring.»
Industry innovation leaders, like GE Healthcare, see value in this continuing collaboration as we look to bring groundbreaking discoveries to the clinical setting — which ultimately impacts patient care.»
«Dendritic cells are essential for prompting the immune response against malignant cells and for driving the clinical success of cancer immunotherapy, but their function is often defective in cancer patients,» said Dmitry I. Gabrilovich, M.D., Ph.D., Christopher M. Davis Professor and program leader of the Immunology, Microenvironment & Metastasis Program at Wistar.
University of Calgary researchers including Luchman, Weiss and Dr. Greg Cairncross — director of SACRI, and leader of the Terry Fox Research Institute (TFRI) «Therapeutic Targeting of Glioblastoma research program at the university — are now working with cancer researchers Dr. Warren Mason (Princess Margaret Cancer Centre in Toronto) and Dr. Lesley Seymour (Director of the NCIC Clinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with gliobClinical Trials Group's Investigational New Drug Program), and drug manufacturer AstraZeneca, to plan a clinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with gliobclinical trial testing a similar, but newer, drug related to AZD8055 (called AZD2014), in combination with TMZ, in patients with glioblastoma.
«The treatment of multiple myeloma has improved significantly in recent years with the introduction of therapies such as proteasome inhibitors [which interfere with tumor cells» protein - disposal system] and potent immuno - modulatory agents,» said the paper's senior author and lead investigator, Paul Richardson, MD, clinical program leader and director of clinical research at Dana - Farber's Jerome Lipper Multiple Myeloma Center, and the R.J. Corman professor at Harvard Medical School.
«That is an enormous advantage, both in research and in clinical diagnostic practice,» research team leader Walch says, assessing the new possibilities.
Another widely accepted conclusion in the Red Team report is that it is a problem that many staff working in the Clinical Center report to leaders at their institutes, and not the center's leadership.
Our team includes some of the world's finest thought leaders in protein homeostasis, medicinal chemistry, biology and the clinical sciences.
«The 64 [current and past] CTSA hubs include the nation's most experienced and creative senior investigators, and very large investments and commitments from their host institutions,» explains Harry Selker, leader of the CTSAs at Tufts University in Medford, Massachusetts, and chair of the Clinical Research Forum, an advocacy group in Washington, D.C., that represents the CTSAs.
«Many children unnecessarily receive broad - spectrum antibiotics for common infections, which can lead to antibiotic resistance and unnecessary side effects,» said study leader Jeffrey Gerber, MD, PhD, associate director for Inpatient Research Activities in the Center for Pediatric Clinical Effectiveness at Children's Hospital of Philadelphia (CHOP).
If the tumor is large or there's obvious evidence that the cancer is in the lymph nodes, you take them out,» said author Julie Ann Sosa, M.D., chief of endocrine surgery and leader of the endocrine neoplasia diseases group at the Duke Clinical Research Institute and the Duke Cancer Institute.
George is a leader in the experimental use of TMS to alleviate depression, one of the biggest clinical hopes for the technique.
Two of three patients from the first clinical test published 2 years ago are also in remission more than 2.5 years later, one after relapsing and then receiving a PD - 1 inhibitor, says trial leader Gerald Linette of the University of Pennsylvania.
Eye and Ear is a Harvard Medical School teaching hospital and trains future medical leaders in ophthalmology and otolaryngology, through residency as well as clinical and research fellowships.
«We saw a modest increase in treadmill walking time for patients treated with GM - CSF, compared to placebo,» says study leader Arshed Quyyumi, MD, professor of medicine at Emory University School of Medicine and co-director of the Emory Clinical Cardiovascular Research Institute.
* Define and improve standards of clinical care * Generate new knowledge in clinical and basic sciences * Provide a diverse and inspiring educational environment * Disseminate knowledge and expertise to our community and scientific colleagues * Foster the advancement of clinical and research leaders
«Clinical and research leaders in cancer genomics are making tremendous progress towards bringing precision medicine to cancer patients, but genomic data interpretation is a significant obstacle, and that's where Watson can help.»
2016 - present Internist in charge, Clinic of Myositis, Unit of Clinical Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milano 2013 - present Associate Professor of Internal Medicine, Università Vita - Salute San Raffaele, Milano 2013 - present Clinical Coordinator, Autoimmunity and Gender Medicine, IRCCS Ospedale San Raffaele, Milano 2009 - present Group leader, Innate Immunity and Tissue Remodeling Unit, IRCCS Ospedale San Raffaele, Milano 2002 - present Internist in charge, High Risk Pregnancy Unit, Department of Obstetrics and Gynecology, IRCCS Ospedale San Raffaele, Milano 2003 - 2013 Physician Scientist, Division of Internal Medicine, IRCCS Ospedale San Raffaele, Milano 1999 - 2002 Intern, Division of Internal Medicine, IRCCS Ospedale San Raffaele Milano 1997 - 1999 PhD student, Laboratory of Tumor Immunology, IRCCS Ospedale San Raffaele, Milano 1995 - 1997 Postdoc, Center d'Immunologie INSERM - CNRS de Marseille - Luminy, Marseille, France 1994 - 1995 Fellow, Laboratory of Tumor Immunology, IRCCS Ospedale San Raffaele, Milano
O'Rourke is a world renowned key opinion leader in targeted immunotherapies for glioblastoma patients and is the co-inventor and clinical author of the study that laid the foundation for the ISOMA Diagnostics technology.
We are an international leader in translating scientific discovery into clinical therapies.
Knowledge gained in the classroom compels medical students to serve as leaders in real - world applications in Puentes De Salud, United Community Clinic (which was recently profiled by the Penn Current), and other clinical opportunities throughout Philadelphia.
Abramson Cancer Center has been a national leader in developing and conducting clinical trials for the prevention, diagnosis and treatment of cancer.
Joining Mr. Solomon on the panel are leaders in neuroscience drug development, Richard Mohs, VP of Neuroscience Clinical Development at Eli Lilly, Rajesh Ranganathan, Director of the Office of Translational Research at NIH / NINDS, and Rudolph Tanzi, Vice-Chair of Neurology and Director of Genetics and Aging Research Unit at Harvard Medical School.
Penn recently joined a national, multi-center study — TRACK TBI (Transforming Research and Clinical Knowledge in Traumatic Brain Injury)-- which hopes to develop «methods to identify patients who have a particular injury mechanism, who can then be targeted by a specific therapy,» said Diaz - Arrastia, who is one of the study's national leaders.
To develop future leaders in academic medical physics through this clinical training, research opportunities and graded responsibility within the program.
The program will expand clinical care, education and research opportunities related to adults with chronic debilitating disease and poise the institution as a national leader in the emerging field of palliative care.
Bhardwaj, a CRI Clip Investigator and Clinical Team Leader who is also involved in CRI's Tumor neoantigEn SeLection Alliance (TESLA), first discussed the computational pipeline that her team is using to identify patient - specific neoantigens to target via vaccines.
We are leaders in cancer medicine providing patients with access to clinical trials and new, breakthrough therapies.
We are a leader in clinical trials for Ewing sarcoma; five - year event - free survival rates are now at about 70 percent.
According to Dr Adil Mardinoglu, SciLifeLab Fellow and leader of the systems biology effort in the project: «We are now in possession of incredibly powerful systems biology tools for medical research, allowing, for the first time, genome - wide analysis of individual patients with regards to the consequence of their expression profiles for clinical survival.»
The Global Genomic Medicine Collaborative (G2MC) is an action collaborative among global leaders in the implementation of genomic medicine in clinical care.
«As a national leader in designing, conducting and analyzing all phases of clinical trials, the University of Chicago is well positioned to play a leadership role in the new network,» said Michelle Le Beau, PhD, Arthur and Marian Edelstein Professor of Medicine and Director of the University of Chicago Medicine Comprehensive Cancer Center.
The Olivia Newton - John Cancer Research Institute is recruiting Group Leaders with established track records in fundamental cancer research to strengthen our clinical and laboratory partnership programs.
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care; Hutch study finds CMV viral load can act as surrogate endpoint for clinical trials; A new target for Tumor Paint: BLZ - 100 lights up head and neck cancers; Dr. Stephen Tapscott appointed to NIAMS advisory council
Lugano, Switzerland, 21 April 2017 — The European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) have announced that the 2017 Heine H. Hansen (HHH) Award will be given to Rafal Dziadziuszko, a global leader in clinical thoracic oncology.
The program is unique in its concentration of nationally and internationally recognized leaders in the areas of new drug development, cell and gene therapy and design and conduct of both local and national clinical trials through the Children's Oncology Group (COG).